CFML
LNAI

COMPASS FINANCIAL MANAGEMENT LLC’s Lunai Bioworks LNAI Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409 Buy
+125
New +$344 ﹤0.01% 1429

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's LNAI Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Lunai Bioworks (LNAI) in Q2 2026: 125 shares worth $409. The stake represents ﹤0.01% of the portfolio and ranks #1429 among its holdings.

7 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 125 shares of Lunai Bioworks worth $409 as of Q2 2026.
  • Lunai Bioworks was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • Lunai Bioworks made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1429 holding.
  • 7 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.